These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 20676683)
1. Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug. Chambers E; Ryan LA; Hoey EM; Trudgett A; McFerran NV; Fairweather I; Timson DJ Parasitol Res; 2010 Oct; 107(5):1257-64. PubMed ID: 20676683 [TBL] [Abstract][Full Text] [Related]
2. A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. Robinson MW; McFerran N; Trudgett A; Hoey L; Fairweather I J Mol Graph Model; 2004 Dec; 23(3):275-84. PubMed ID: 15530823 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of liver fluke β-tubulin isotypes at selected life cycle stages. Fuchs MA; Ryan LA; Chambers EL; Moore CM; Fairweather I; Trudgett A; Timson DJ; Brennan GP; Hoey EM Int J Parasitol; 2013 Dec; 43(14):1133-9. PubMed ID: 24162076 [TBL] [Abstract][Full Text] [Related]
5. Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica. Solana H; Scarcella S; Virkel G; Ceriani C; Rodríguez J; Lanusse C Vet Res Commun; 2009 Feb; 33(2):163-73. PubMed ID: 18726703 [TBL] [Abstract][Full Text] [Related]
6. Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes. Ryan LA; Hoey E; Trudgett A; Fairweather I; Fuchs M; Robinson MW; Chambers E; Timson DJ; Ryan E; Feltwell T; Ivens A; Bentley G; Johnston D Mol Biochem Parasitol; 2008 May; 159(1):73-8. PubMed ID: 18372053 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of a beta-tubulin gene from the liver fluke, Fasciola hepatica. Robinson MW; Hoey EM; Fairweather I; Dalton JP; McGonigle S; Trudgett A Int J Parasitol; 2001 Sep; 31(11):1264-8. PubMed ID: 11513896 [TBL] [Abstract][Full Text] [Related]
8. The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica. Fetterer RH J Vet Pharmacol Ther; 1986 Mar; 9(1):49-54. PubMed ID: 3701915 [TBL] [Abstract][Full Text] [Related]
9. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Solana HD; Sallovitz JM; Lanusse CE; Rodriguez JA Methods Find Exp Clin Pharmacol; 2002; 24(1):7-13. PubMed ID: 11980387 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of β-tubulin isotypes in different life stages of Parascaris spp after exposure to thiabendazole. Tydén E; Skarin M; Andersson-Franko M; Sjöblom M; Höglund J Mol Biochem Parasitol; 2016; 205(1-2):22-8. PubMed ID: 26880419 [TBL] [Abstract][Full Text] [Related]
11. Protein Modelling and Molecular Docking Analysis of Fasciola hepatica β-Tubulin's Interaction Sites, with Triclabendazole, Triclabendazole Sulphoxide and Triclabendazole Sulphone. Olivares-Ferretti P; Beltrán JF; Salazar LA; Fonseca-Salamanca F Acta Parasitol; 2023 Sep; 68(3):535-547. PubMed ID: 37330945 [TBL] [Abstract][Full Text] [Related]
12. Interactions of Caenorhabditis elegans β-tubulins with the microtubule inhibitor and anthelmintic drug albendazole. Pallotto LM; Dilks CM; Park YJ; Smit RB; Lu BT; Gopalakrishnan C; Gilleard JS; Andersen EC; Mains PE Genetics; 2022 Jul; 221(4):. PubMed ID: 35731216 [TBL] [Abstract][Full Text] [Related]
13. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer. Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of drugs and other xenobiotics in giant liver fluke (Fascioloides magna). Prchal L; Vokřál I; Kašný M; Rejšková L; Zajíčková M; Lamka J; Skálová L; Lecová L; Szotáková B Xenobiotica; 2016; 46(2):132-40. PubMed ID: 26153440 [TBL] [Abstract][Full Text] [Related]
15. Individual expression of recombinant alpha- and beta-tubulin from Haemonchus contortus: polymerization and drug effects. Oxberry ME; Geary TG; Winterrowd CA; Prichard RK Protein Expr Purif; 2001 Feb; 21(1):30-9. PubMed ID: 11162384 [TBL] [Abstract][Full Text] [Related]
16. Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen'). Buchanan JF; Fairweather I; Brenna GP; Trudgett A; Hoey EM Parasitology; 2003 Feb; 126(Pt 2):141-53. PubMed ID: 12636352 [TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276 [TBL] [Abstract][Full Text] [Related]
18. Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole. Robinson MW; Trudgett A; Hoey EM; Fairweather I Parasitology; 2002 Mar; 124(Pt 3):325-38. PubMed ID: 11922434 [TBL] [Abstract][Full Text] [Related]
19. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. Mottier L; Alvarez L; Fairweather I; Lanusse C J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820 [TBL] [Abstract][Full Text] [Related]